RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.9275
-0.0201 (-2.12%)
At close: Jul 7, 2026, 4:00 PM EDT
0.9000
-0.0275 (-2.96%)
Pre-market: Jul 8, 2026, 4:30 AM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $41.83 million as of July 8, 2026. Its market cap has decreased by -17.12% in one year.
Market Cap
41.83M
Enterprise Value
29.65M
1-Year Change
-17.12%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $41.83M, a decrease of -39.06%. That is a compound annual growth rate of -9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 41.83M | 35.86% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
| Aug 26, 2021 | 68.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PDS Biotechnology | 47.62M |
| Metagenomi Therapeutics | 47.44M |
| Hyperion DeFi | 47.14M |
| ABVC BioPharma | 45.49M |
| INmune Bio | 45.19M |
| Apollomics | 42.95M |
| Estrella Immunopharma | 42.28M |
| Genenta Science | 40.58M |